Business Context and Reporting Period
Company: On Assignment, Inc. (Note: Input metadata listed "Everforth Inc," but the filing text identifies the registrant as On Assignment, Inc.)
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: June 30, 2008
Business Overview: A diversified professional staffing firm operating in four segments: Life Sciences, Healthcare (Nurse Travel and Allied Healthcare), Physician (VISTA Staffing Solutions), and IT and Engineering (Oxford Global Resources). The company provides contract, contract-to-permanent, and direct placement services.
Key Financial Metrics
All figures in thousands, except per share data.
| Metric | Three Months Ended June 30, 2008 |
Six Months Ended June 30, 2008 |
|---|---|---|
| Revenues | $156,082 | $308,495 |
| Gross Profit | $50,664 | $98,092 |
| Gross Margin | 32.5% | 31.8% |
| Operating Income | $11,838 | $19,569 |
| Net Income | $6,092 | $8,495 |
| Diluted EPS | $0.17 | $0.24 |
| Cash and Equivalents | $40,051 (Balance Sheet) | N/A |
| Operating Cash Flow | N/A | $15,445 |
| Total Debt | $135,912 (Current + Long-term) | N/A |
| Working Capital | $91,906 | N/A |
Material Changes vs. Prior Period
- Revenue Growth: Revenues increased 8.5% year-over-year (Q2) and 15.8% (YTD). Growth was driven by the IT and Engineering (+15.7% Q2, +40.5% YTD), Physician (+20.4% Q2, +17.4% YTD), and Healthcare (+5.0% Q2, +4.7% YTD) segments. Life Sciences revenues declined slightly (-3.8% Q2, -0.5% YTD).
- Profitability: Net income more than doubled in Q2 ($6.1M vs. $2.9M) and YTD ($8.5M vs. $3.8M). Operating margins expanded to 7.6% in Q2 from 5.0% in the prior year.
- Expense Management: SG&A expenses decreased 0.4% in Q2 and increased 7.2% YTD. The Q2 decrease was aided by lower depreciation/amortization and a legal settlement gain. YTD increases were due to higher sales headcount and commissions, partially offset by lower amortization.
- Acquisition Activity: Net cash used in investing activities dropped significantly to $14.3M (YTD 2008) from $231.5M (YTD 2007), as the major acquisitions of Oxford and VISTA occurred in 2007.
Guidance, Outlook, and Risks
- Outlook: Management expects capital expenditures of approximately $9.0 million for 2008. The company believes its working capital and operating cash flows are sufficient to fund operations and debt obligations for the next 12 months.
- Debt Covenants: The company is in compliance with all financial covenants under its $165.0 million senior secured credit facility. The term loan requires principal payments of $0.3 million per quarter starting Q1 2009, plus potential excess cash flow payments.
- Contingent Consideration: There is potential for additional earn-out payments of $11.0 million related to the 2008 performance of VISTA and Oxford acquisitions.
- Legal Proceedings: The company settled the Oxford vs. Black Diamond litigation in July 2008, securing economic and non-economic relief. No other material legal proceedings are pending.
- Risks: Key risks include labor market conditions, ability to retain qualified consultants, and integration of acquisitions. The company notes that white-collar unemployment remains low (2.3%), supporting demand for specialized staffing.
Investor Verification Checklist
- Debt Structure: Verify the terms of the $165M credit facility, specifically the interest rate swap fixing $73M of debt at 4.9425% and the reset date for the remaining balance (Sept 30, 2008).
- Segment Performance: Confirm the sustainability of growth in the IT and Engineering segment, which drove the majority of YTD revenue increases.
- Intangible Assets: Review the amortization schedule for the $36.2M in identifiable intangible assets, noting the significant reduction in amortization expense in 2008 due to the completion of certain intangible amortization.
- Self-Insurance Reserves: Assess the adequacy of the $9.0M reserve for workers' compensation and medical malpractice, which is based on historical estimates.
- Stock-Based Compensation: Note the $3.1M expense for the six months ended June 30, 2008, and the $7.5M in unrecognized compensation expense related to unvested options and RSUs.